Carregant...
Discovery of a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia
[Image: see text] Nicotinic acid has been used clinically for decades to control serum lipoproteins. Nicotinic acid lowers very low-density lipoprotein (VLDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, and lipoprotein-a (LPa), and it is also effective in raising high-density lipoprotein...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Chemical Society
2010
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4017979/ https://ncbi.nlm.nih.gov/pubmed/24900295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml100251u |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|